NL-OMON35144已完成4 期
Drug Eluting Balloon in Acute Myocardial Infarction - DEB-AMI
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age: 18-80 year
- •- STEMI within 12 hours of onset of complaints
- •- Candidate for primary PCI with stent-implantation
- •- Successful thrombus aspiration defined by no angiographic signs of thrombus a the site of plaque rupture and TIMI flow * 1.
排除标准
- •- Unable to give written informed consent
- •- Previous PCI or CABG of infarct related vessel
- •- Left main stenosis * 50%.
- •- Severe triple vessel disease with stenosis * 50% in 3 epicardial coronary arteries.
- •- Target vessel reference diameter < 2.5 and > 4.0 mm
- •- Target lesion length < 25 mm
- •- Intolerance for aspirin or clopidogrel
- •- Life expentancy < 12 month
研究者
相似试验
进行中（未招募）
1 期
Acute Myocardial infarction Upbound to percutaneous coronary intervention, immediately (STEMI) or in the Next three Days (NSTEMI), and randomized to Subcutaneous Evolocumab or Normal strategies to reach guidelines LDL objectives in the real-world- The AMUNDSEN-real studyEUCTR2021-000573-80-FRAPHP DRCI
招募中
2 期
RAIB-TACE for Hepatocellular Carcinoma refractory or intolerant to Atezolizumab plus BevacizumabHepatocellular Carcinoma, atezolizumab, bevacizumab, TACED006528Hepatocellular CarcinomaJPRN-jRCTs031210114Hasegawa Naoyuki19
已完成
2 期
RAIB-TACE for the Patients with Hepatocellular Carcinoma beyond Up-to 7 CriteriaHepatocellular CarcinomaJPRN-jRCTs031200334Hoshiai Sodai19
撤回
不适用
Drug eluting BALLoon angioplasty to prime bifuRcation lesiOns for stenting: a prOspective randoMized trialNL-OMON33521Sint Antonius Ziekenhuis200
已完成
不适用
Cypher drug-Eluting stent: a Zwolle Acute myocardial infarction Randomised trialAcute myocardial infarctionISRCTN90526229Isala klinieken (The Netherlands)352